The Oxford Science Park is majority owned by Magdalen College, Oxford, upholding its research heritage and its strategy to support discovery, innovation and entrepreneurship. Providing an influential science and technology environment, the Park has ambitious plans to create an additional 500,000+ sq ft of office and laboratory space over the next 3 years alongside its strategic partner GIC. This additional capacity will support the growth of businesses already based on the Park, providing flexible workspace accommodation, and enabling new companies to enjoy the Park’s exceptional environment and collegiate and collaborative ethos. TOSP is home to 2,700 people and more than 130 businesses. These range from start-ups based in the Magdalen Centre innovation hub to major international companies and include Blue Earth Diagnostics, MiroBio, OrganOx, OxSonics Therapeutics, Oxford Nanopore Technologies, OXGENE, ProImmune, Oxford Science Enterprises, Evox Therapeutics, Vaccitech, Exscientia, Sensyne Health and Intuitive Surgical.
